عرض مصدر فيزتيبينت

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 399133414
| IUPAC_name = (2''S'')-''N''-[(1''R'')-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-''N''-methylpiperazine-1-carboxamide
| image = Vestipitant structure.svg

<!--Clinical data-->
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US =
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| excretion =

<!--Identifiers-->
| IUPHAR_ligand = 5757
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 334476-64-1
| CAS_supplemental =
| ATC_prefix = none
| ATC_suffix =
| PubChem = 9832383
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = S052TOI9BI
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 522987
| ChemSpiderID = 8008111

<!--Chemical data-->
| C=23 | H=21 | F=10 | N=3 | O=1 
| molecular_weight = 545.416 g/mol
| smiles = FC(F)(F)c1cc(F)ccc1C2CNCCN2C(=O)N(C)C(C)c3cc(C(F)(F)F)cc(c3)C(F)(F)F
| StdInChI = 1S/C23H24F7N3O/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3/t14-,20-/m1/s1
| StdInChIKey = SBBYBXSFWOLDDG-JLTOFOAXSA-N
}}

'''فيزتيبينت Vestipitant''' هو دواء طور من قبل شركة جلاكسو سميث كلاين، يعمل بمثابة مناهض انتقائي لمستقبلات NK1. قيد التطوير كدواء مضاد للقىء ومزيل للقلق المحتمل، وكعلاج لل[[طنين]] والأرق.

{{Antiemetics and antinauseants}}
{{Antidepressants}}
{{Anxiolytics}}
{{Neuropeptide agonists and antagonists}}

[[Category:NK1 receptor antagonists]]
[[Category:Organofluorides]]
[[Category:Piperazines]]
[[Category:Amides]]

{{gastrointestinal-drug-stub}}
{{nervous-system-drug-stub}}